Stay updated with breaking news from Nasdaq Docs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Doximity (NASDAQ:DOCS – Get Free Report) and Venus Acquisition (NASDAQ:VENA – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership. Analyst Ratings This is a summary of recent recommendations […]
Doximity, Inc. (NASDAQ:DOCS – Get Free Report) Director Timothy S. Cabral sold 7,500 shares of the company’s stock in a transaction dated Wednesday, July 12th. The stock was sold at an average price of $35.00, for a total value of $262,500.00. Following the completion of the sale, the director now owns 4,714 shares in the […]
Doximity, Inc. (NASDAQ:DOCS – Free Report) Director Timothy S. Cabral sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $33.80, for a total transaction of $338,000.00. Following the completion of the transaction, the director now owns 4,714 shares in […]
Neo Ivy Capital Management grew its holdings in shares of Doximity, Inc. (NASDAQ:DOCS – Get Rating) by 12,750.0% during the 4th quarter, HoldingsChannel.com reports. The firm owned 1,542 shares of the company’s stock after buying an additional 1,530 shares during the period. Neo Ivy Capital Management’s holdings in Doximity were worth $52,000 as of its […]
Doximity, Inc. (NASDAQ:DOCS – Get Rating) – Research analysts at SVB Leerink lifted their FY2024 earnings per share (EPS) estimates for Doximity in a report released on Tuesday, June 6th. SVB Leerink analyst S. Davis now expects that the company will post earnings of $0.58 per share for the year, up from their prior estimate […]